drugset / Trial / NCT00213512
Effect of Anti CD20 in Pemphigus Desease
Non-randomizedSingle-groupOpen-labelHealth-services research
Summary
to treat in an open non comparative clinical study patients presenting pemphigus with corticodependance, corticoresistance and contre-indication to systemic steroids.
Timeline
- Start
- 2003-06
- Primary completion
- 2006-06
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | — |